Medical device stocks include companies manufacturing surgical instruments, diagnostic equipment, implants, and therapeutic devices. Our AI evaluates FDA approval pipelines, recurring revenue, and R&D efficiency from SEC filings.
Best Medical Devices Stocks to Buy in 2026
Top-rated medical devices stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: May 2026
DXCM
Confidence
86%
ISRG
Confidence
85%
UFPT
Confidence
85%
IDXX
Confidence
82%
KRYS
Confidence
82%
RSMDF
Confidence
82%
NBIX
Confidence
81%
ELMD
Confidence
80%
AMGN
Confidence
79%
PEN
Confidence
78%
IRMD
Confidence
78%
STE
Confidence
78%
All Medical Devices Stocks (341)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| UEEC | United Health Products, Inc. | STRONG SELL | 98% | View Analysis → |
| SIGY | Sigyn Therapeutics, Inc. | STRONG SELL | 98% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | STRONG SELL | 97% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | STRONG SELL | 97% | View Analysis → |
| RBOTW | Vicarious Surgical Inc. | STRONG SELL | 96% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | STRONG SELL | 96% | View Analysis → |
| IRME | IR-Med, Inc. | STRONG SELL | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | STRONG SELL | 96% | View Analysis → |
| COCHW | Envoy Medical, Inc. | STRONG SELL | 96% | View Analysis → |
| CDIOW | Cardio Diagnostics Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| BZYR | BURZYNSKI RESEARCH INSTITUTE INC | STRONG SELL | 96% | View Analysis → |
| ZIVOW | Zivo Bioscience, Inc. | STRONG SELL | 95% | View Analysis → |
| YBGJ | Yubo International Biotech Ltd | STRONG SELL | 95% | View Analysis → |
| XAIR | Beyond Air, Inc. | STRONG SELL | 95% | View Analysis → |
| VVOS | Vivos Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| VTAK | Catheter Precision, Inc. | STRONG SELL | 95% | View Analysis → |
| VNRX | VOLITIONRX LTD | STRONG SELL | 95% | View Analysis → |
| VERO | Venus Concept Inc. | STRONG SELL | 95% | View Analysis → |
| TVGNW | Tevogen Bio Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| TIL | Instil Bio, Inc. | STRONG SELL | 95% | View Analysis → |
| STSSW | Sharps Technology Inc. | STRONG SELL | 95% | View Analysis → |
| STME | Stimcell Energetics Inc. | STRONG SELL | 95% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | STRONG SELL | 95% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | STRONG SELL | 95% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | STRONG SELL | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| POSC | POSITRON CORP | STRONG SELL | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | STRONG SELL | 95% | View Analysis → |
| PLUR | Pluri Inc. | STRONG SELL | 95% | View Analysis → |
| PAVM | PAVmed Inc. | STRONG SELL | 95% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | STRONG SELL | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | STRONG SELL | 94% | View Analysis → |
| IVF | INVO Fertility, Inc. | STRONG SELL | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | STRONG SELL | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | STRONG SELL | 94% | View Analysis → |
| CRGT | Cortigent, Inc. | SELL | 94% | View Analysis → |
| CPMV | Mosaic ImmunoEngineering Inc. | STRONG SELL | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | STRONG SELL | 94% | View Analysis → |
| CEROW | CERO THERAPEUTICS HOLDINGS, INC. | STRONG SELL | 94% | View Analysis → |
| BCAB | BioAtla, Inc. | STRONG SELL | 93% | View Analysis → |
| GCTK | Glucotrack, Inc. | STRONG SELL | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | STRONG SELL | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | STRONG SELL | 93% | View Analysis → |
| EXOZ | EXOZYMES INC. | STRONG SELL | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | STRONG SELL | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| CRIS | CURIS INC | STRONG SELL | 92% | View Analysis → |
| ZEOX | Zeo ScientifiX, Inc. | STRONG SELL | 92% | View Analysis → |
| VANI | Vivani Medical, Inc. | STRONG SELL | 92% | View Analysis → |
| VACHW | Voyager Acquisition Corp./Cayman Islands | STRONG SELL | 92% | View Analysis → |
| SLDB | Solid Biosciences Inc. | STRONG SELL | 92% | View Analysis → |
| SINT | Sintx Technologies, Inc. | STRONG SELL | 92% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | STRONG SELL | 92% | View Analysis → |
| PHGE | BiomX Inc. | STRONG SELL | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | STRONG SELL | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | STRONG SELL | 92% | View Analysis → |
| NVACW | Profusa, Inc. | STRONG SELL | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | STRONG SELL | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | STRONG SELL | 92% | View Analysis → |
| MBOT | Microbot Medical Inc. | STRONG SELL | 92% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| FEMY | FEMASYS INC | STRONG SELL | 92% | View Analysis → |
| EDIT | Editas Medicine, Inc. | STRONG SELL | 92% | View Analysis → |
| DBVTF | DBV Technologies S.A. | STRONG SELL | 92% | View Analysis → |
| CUBT | Curative Biotechnology Inc | SELL | 92% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CLDWW | Calidi Biotherapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | STRONG SELL | 91% | View Analysis → |
| DNABW | Ginkgo Bioworks Holdings, Inc. | STRONG SELL | 91% | View Analysis → |
| CVM | CEL SCI CORP | STRONG SELL | 91% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | STRONG SELL | 91% | View Analysis → |
| TIVC | Tivic Health Systems, Inc. | STRONG SELL | 90% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | STRONG SELL | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | STRONG SELL | 90% | View Analysis → |
| NUWE | Nuwellis, Inc. | STRONG SELL | 90% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | STRONG SELL | 90% | View Analysis → |
| FEED | ENvue Medical, Inc. | STRONG SELL | 90% | View Analysis → |
| DRIO | DarioHealth Corp. | STRONG SELL | 90% | View Analysis → |
| CV | CapsoVision, Inc | STRONG SELL | 90% | View Analysis → |
| CUPR | Cuprina Holdings (Cayman) LTD | SELL | 90% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | SELL | 90% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | SELL | 89% | View Analysis → |
| IBRX | ImmunityBio, Inc. | STRONG SELL | 89% | View Analysis → |
| ENTX | Entera Bio Ltd. | SELL | 89% | View Analysis → |
| VIR | Vir Biotechnology, Inc. | STRONG SELL | 88% | View Analysis → |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | STRONG SELL | 88% | View Analysis → |
| STRO | SUTRO BIOPHARMA, INC. | STRONG SELL | 88% | View Analysis → |
| SPAI | Safe Pro Group Inc. | STRONG SELL | 88% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | STRONG SELL | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | STRONG SELL | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | STRONG SELL | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OCGN | Ocugen, Inc. | STRONG SELL | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | STRONG SELL | 88% | View Analysis → |
| LNSR | LENSAR, Inc. | STRONG SELL | 88% | View Analysis → |
| LFWD | Lifeward Ltd. | STRONG SELL | 88% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | STRONG SELL | 88% | View Analysis → |
| HSCSW | HeartSciences Inc. | STRONG SELL | 88% | View Analysis → |
| RGNX | REGENXBIO Inc. | STRONG SELL | 88% | View Analysis → |
| RDGL | VIVOS INC | STRONG SELL | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | STRONG SELL | 88% | View Analysis → |
| INMB | Inmune Bio, Inc. | SELL | 88% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | SELL | 88% | View Analysis → |
| ELUT | ELUTIA INC. | SELL | 88% | View Analysis → |
| ECOR | electroCore, Inc. | SELL | 88% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | STRONG SELL | 87% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | SELL | 87% | View Analysis → |
| MLSS | MILESTONE SCIENTIFIC INC. | STRONG SELL | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | SELL | 87% | View Analysis → |
| DRTSW | Alpha Tau Medical Ltd. | SELL | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | SELL | 87% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | SELL | 87% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | SELL | 87% | View Analysis → |
| ARAY | ACCURAY INC | SELL | 86% | View Analysis → |
| DXCM | DEXCOM INC | BUY | 86% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | STRONG SELL | 86% | View Analysis → |
| NSPR | InspireMD, Inc. | STRONG SELL | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | SELL | 86% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | SELL | 86% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | SELL | 86% | View Analysis → |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | SELL | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | SELL | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | SELL | 86% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | SELL | 86% | View Analysis → |
| ISRG | INTUITIVE SURGICAL INC | BUY | 85% | View Analysis → |
| XFOR | X4 Pharmaceuticals, Inc | STRONG SELL | 85% | View Analysis → |
| VYGR | Voyager Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| VYCO | VYCOR MEDICAL INC | STRONG SELL | 85% | View Analysis → |
| VIVS | VivoSim Labs, INC. | STRONG SELL | 85% | View Analysis → |
| UFPT | UFP TECHNOLOGIES INC | BUY | 85% | View Analysis → |
| TNONW | Tenon Medical, Inc. | STRONG SELL | 85% | View Analysis → |
| TNDM | TANDEM DIABETES CARE INC | STRONG SELL | 85% | View Analysis → |
| TLSIW | TriSalus Life Sciences, Inc. | STRONG SELL | 85% | View Analysis → |
| STEX | Streamex Corp. | STRONG SELL | 85% | View Analysis → |
| SSII | SS Innovations International, Inc. | STRONG SELL | 85% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | STRONG SELL | 85% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| PROK | PROKIDNEY CORP. | STRONG SELL | 85% | View Analysis → |
| PCVX | Vaxcyte, Inc. | STRONG SELL | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | SELL | 85% | View Analysis → |
| NRXS | Neuraxis, INC | STRONG SELL | 85% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | SELL | 85% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CVRX | CVRx, Inc. | SELL | 85% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | SELL | 85% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | SELL | 85% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | SELL | 84% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | STRONG SELL | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | STRONG SELL | 84% | View Analysis → |
| NTRBW | NutriBand Inc. | SELL | 84% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | SELL | 84% | View Analysis → |
| IRIX | IRIDEX CORP | SELL | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | SELL | 84% | View Analysis → |
| ENOV | Enovis CORP | SELL | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | SELL | 84% | View Analysis → |
| ECIA | ENCISION INC | SELL | 84% | View Analysis → |
| CTSO | Cytosorbents Corp | SELL | 84% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | SELL | 84% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | SELL | 84% | View Analysis → |
| HUMAW | Humacyte, Inc. | STRONG SELL | 83% | View Analysis → |
| EVAX | Evaxion A/S | SELL | 83% | View Analysis → |
| CGON | CG Oncology, Inc. | SELL | 83% | View Analysis → |
| QDEL | QuidelOrtho Corp | SELL | 82% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | STRONG BUY | 82% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | SELL | 82% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | BUY | 82% | View Analysis → |
| LAKE | LAKELAND INDUSTRIES INC | SELL | 82% | View Analysis → |
| RSMDF | RESMED INC | STRONG BUY | 82% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | STRONG SELL | 82% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | SELL | 82% | View Analysis → |
| NXL | Nexalin Technology, Inc. | STRONG SELL | 82% | View Analysis → |
| MYO | MYOMO, INC. | SELL | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | SELL | 82% | View Analysis → |
| INGN | Inogen Inc | SELL | 82% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | BUY | 81% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | SELL | 81% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | SELL | 80% | View Analysis → |
| LUNG | Pulmonx Corp | SELL | 80% | View Analysis → |
| PASG | Passage BIO, Inc. | STRONG SELL | 80% | View Analysis → |
| KOD | Kodiak Sciences Inc. | SELL | 80% | View Analysis → |
| ELMD | Electromed, Inc. | BUY | 80% | View Analysis → |
| CBLL | Ceribell, Inc. | SELL | 80% | View Analysis → |
| AMGN | AMGEN INC | BUY | 79% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | SELL | 79% | View Analysis → |
| STIM | Neuronetics, Inc. | SELL | 78% | View Analysis → |
| SGRY | Surgery Partners, Inc. | SELL | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | SELL | 78% | View Analysis → |
| PEN | Penumbra Inc | BUY | 78% | View Analysis → |
| IRMD | IRADIMED CORP | BUY | 78% | View Analysis → |
| CERS | CERUS CORP | SELL | 78% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | SELL | 78% | View Analysis → |
| VOR | Vor Biopharma Inc. | SELL | 78% | View Analysis → |
| UTMD | UTAH MEDICAL PRODUCTS INC | HOLD | 78% | View Analysis → |
| TNYA | Tenaya Therapeutics, Inc. | SELL | 78% | View Analysis → |
| TELA | TELA Bio, Inc. | SELL | 78% | View Analysis → |
| STE | STERIS plc | BUY | 78% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | SELL | 78% | View Analysis → |
| SMTI | Sanara MedTech Inc. | SELL | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | SELL | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PRME | Prime Medicine, Inc. | STRONG SELL | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | SELL | 78% | View Analysis → |
| NEOG | NEOGEN CORP | SELL | 78% | View Analysis → |
| IMA | ImageneBio, Inc. | SELL | 78% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | BUY | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | SELL | 78% | View Analysis → |
| MNESP | MSA Safety Inc | BUY | 78% | View Analysis → |
| IVVD | Invivyd, Inc. | SELL | 78% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | SELL | 78% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | BUY | 78% | View Analysis → |
| CDRE | Cadre Holdings, Inc. | BUY | 78% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | BUY | 77% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | BUY | 77% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | BUY | 77% | View Analysis → |
| LONA | LeonaBio, Inc. | SELL | 77% | View Analysis → |
| MASI | MASIMO CORP | BUY | 76% | View Analysis → |
| EW | Edwards Lifesciences Corp | SELL | 76% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SELL | 76% | View Analysis → |
| MRNA | Moderna, Inc. | SELL | 76% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | SELL | 76% | View Analysis → |
| ITGR | Integer Holdings Corp | SELL | 76% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | SELL | 76% | View Analysis → |
| HCA | HCA Healthcare, Inc. | BUY | 76% | View Analysis → |
| NEPH | NEPHROS INC | BUY | 76% | View Analysis → |
| LGMK | LogicMark, Inc. | SELL | 76% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | SELL | 76% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | SELL | 76% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | BUY | 76% | View Analysis → |
| CSBR | CHAMPIONS ONCOLOGY, INC. | SELL | 76% | View Analysis → |
| SOLV | Solventum Corp | SELL | 75% | View Analysis → |
| EXEL | EXELIXIS, INC. | BUY | 75% | View Analysis → |
| EMBC | Embecta Corp. | HOLD | 75% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | BUY | 75% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | SELL | 75% | View Analysis → |
| AXGN | Axogen, Inc. | SELL | 75% | View Analysis → |
| MMM | 3M CO | HOLD | 75% | View Analysis → |
| TECH | BIO-TECHNE Corp | HOLD | 75% | View Analysis → |
| SKIN | Beauty Health Co | SELL | 75% | View Analysis → |
| PROF | Profound Medical Corp. | SELL | 75% | View Analysis → |
| AVNS | AVANOS MEDICAL, INC. | SELL | 74% | View Analysis → |
| ARDT | Ardent Health, Inc. | SELL | 74% | View Analysis → |
| ADPT | Adaptive Biotechnologies Corp | HOLD | 74% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | BUY | 74% | View Analysis → |
| OM | Outset Medical, Inc. | SELL | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | SELL | 74% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | SELL | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | STRONG SELL | 74% | View Analysis → |
| CNMD | CONMED Corp | SELL | 74% | View Analysis → |
| ALGN | ALIGN TECHNOLOGY INC | BUY | 73% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | SELL | 73% | View Analysis → |
| PDEX | PRO DEX INC | BUY | 73% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | SELL | 72% | View Analysis → |
| NVNO | enVVeno Medical Corp | SELL | 72% | View Analysis → |
| TWST | Twist Bioscience Corp | HOLD | 72% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | SELL | 72% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | SELL | 72% | View Analysis → |
| BIIB | BIOGEN INC. | HOLD | 72% | View Analysis → |
| BBNX | Beta Bionics, Inc. | SELL | 72% | View Analysis → |
| ZURA | Zura Bio Ltd | HOLD | 72% | View Analysis → |
| VASO | VASO Corp | HOLD | 72% | View Analysis → |
| USAQ | QHSLab, Inc. | SELL | 72% | View Analysis → |
| TSHA | Taysha Gene Therapies, Inc. | SELL | 72% | View Analysis → |
| STXS | Stereotaxis, Inc. | SELL | 72% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | SELL | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | SELL | 72% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | SELL | 72% | View Analysis → |
| PODD | INSULET CORP | BUY | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | BUY | 72% | View Analysis → |
| HYPR | Hyperfine, Inc. | SELL | 72% | View Analysis → |
| MDNC | Medinotec Inc. | BUY | 72% | View Analysis → |
| MDLN | Medline Inc. | BUY | 72% | View Analysis → |
| OFIX | Orthofix Medical Inc. | SELL | 71% | View Analysis → |
| ATRC | AtriCure, Inc. | HOLD | 71% | View Analysis → |
| HAE | HAEMONETICS CORP | BUY | 71% | View Analysis → |
| NPCE | NeuroPace Inc | SELL | 71% | View Analysis → |
| RGEN | REPLIGEN CORP | BUY | 70% | View Analysis → |
| CARL | CARLSMED, INC. | HOLD | 70% | View Analysis → |
| BVS | Bioventus Inc. | SELL | 70% | View Analysis → |
| GKOS | GLAUKOS Corp | HOLD | 70% | View Analysis → |
| XTNT | Xtant Medical Holdings, Inc. | BUY | 70% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | BUY | 70% | View Analysis → |
| FONR | FONAR CORP | HOLD | 70% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | SELL | 69% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| TMDX | TransMedics Group, Inc. | HOLD | 68% | View Analysis → |
| THC | TENET HEALTHCARE CORP | HOLD | 68% | View Analysis → |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | HOLD | 68% | View Analysis → |
| TARA | Protara Therapeutics, Inc. | SELL | 68% | View Analysis → |
| PALI | PALISADE BIO, INC. | SELL | 68% | View Analysis → |
| LIVN | LivaNova PLC | HOLD | 68% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | SELL | 68% | View Analysis → |
| SIBN | SI-BONE, Inc. | BUY | 67% | View Analysis → |
| NVAX | NOVAVAX INC | SELL | 67% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | BUY | 67% | View Analysis → |
| IMVT | Immunovant, Inc. | SELL | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | BUY | 66% | View Analysis → |
| VCEL | Vericel Corp | HOLD | 65% | View Analysis → |
| TECX | Tectonic Therapeutic, Inc. | HOLD | 65% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | HOLD | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | SELL | 65% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | HOLD | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | SELL | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | BUY | 64% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | HOLD | 63% | View Analysis → |
| TARS | Tarsus Pharmaceuticals, Inc. | HOLD | 62% | View Analysis → |
| NVCR | NovoCure Ltd | HOLD | 61% | View Analysis → |
| TKNO | Alpha Teknova, Inc. | SELL | 60% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | SELL | 60% | View Analysis → |
| HTFL | Heartflow, Inc. | HOLD | 60% | View Analysis → |
| NNNN | Anbio Biotechnology | SELL | 60% | View Analysis → |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | HOLD | 58% | View Analysis → |
| INAB | IN8BIO, INC. | SELL | 58% | View Analysis → |
| TCRX | TScan Therapeutics, Inc. | SELL | 50% | View Analysis → |
| VXRT | Vaxart, Inc. | HOLD | 48% | View Analysis → |
| CLGN | CollPlant Biotechnologies Ltd | SELL | 48% | View Analysis → |
| CGEN | COMPUGEN LTD | HOLD | 47% | View Analysis → |
| CLLS | Cellectis S.A. | SELL | 44% | View Analysis → |
| INMD | InMode Ltd. | HOLD | 42% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | HOLD | 41% | View Analysis → |
| EDAP | EDAP TMS SA | HOLD | 39% | View Analysis → |
| CRDL | Cardiol Therapeutics Inc. | HOLD | 39% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | HOLD | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | SELL | 18% | View Analysis → |
| RGNT | REGENTIS BIOMATERIALS LTD. | HOLD | 16% | View Analysis → |
| MEOBF | MESOBLAST LTD | HOLD | 5% | View Analysis → |
Frequently Asked Questions: Medical Devices Stocks
What are the best medical devices stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 40 medical devices stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which medical devices stocks have Strong Buy ratings?
Currently, 2 medical devices stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze medical devices stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Medical devices stocks with 80%+ confidence have the most reliable ratings.
Should I invest in medical devices stocks in 2026?
Our AI analysis shows 40 Buy ratings vs 265 Sell ratings in the medical devices sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are medical devices stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most medical devices stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for medical devices stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.
Compare Top Medical Devices Stocks
Part of: 💊 Healthcare Sector